Cas:214357-95-6 (3S)-1-Methylpyrrolidin-3-amine manufacturer & supplier

We serve Chemical Name:(3S)-1-Methylpyrrolidin-3-amine CAS:214357-95-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(3S)-1-Methylpyrrolidin-3-amine

Chemical Name:(3S)-1-Methylpyrrolidin-3-amine
CAS.NO:214357-95-6
Synonyms:(S)-N-methyl-3-aminopyrrolidine;(S)-1-Methylpyrrolidin-3-amine;(S)-3-Amino-1-methylpyrrolidine;(3S)-1-methyl-3-pyrrolidinamine;(S)-1-Methyl-pyrrolidin-3-ylamine
Molecular Formula:C5H12N2
Molecular Weight:100.16200
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:109.63ºC at 760 mmHg
Density:0.933g/cm3
Index of Refraction:1.476
PSA:29.26000
Exact Mass:100.10000
LogP:0.28740

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (S)-N-methyl-3-aminopyrrolidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-1-Methyl-pyrrolidin-3-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-3-Amino-1-methylpyrrolidine Use and application,(3S)-1-methyl-3-pyrrolidinamine technical grade,usp/ep/jp grade.


Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. (3S)-1-Methylpyrrolidin-3-amine manufacturer Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. (3S)-1-Methylpyrrolidin-3-amine supplier The data will be updated at the upcoming 2019 ASH Annual Meeting next week. (3S)-1-Methylpyrrolidin-3-amine vendor Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said. (3S)-1-Methylpyrrolidin-3-amine factory The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.